CLINICAL_TRIALS
trial_result
· 2012-06-11
Clinical Trial Update: Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia [Phase 2]
Summary
A Phase 2 clinical trial investigated arsenic trioxide in patients with acute myeloid leukemia and the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Leukemia | Phase 2 | Status: COMPLETED